Pub. Date : 2006 Apr 15
PMID : 16287099
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Inhibition of E6-mediated p53 proteasomal degradation by MG132 resulted in elevated levels of active p53 as demonstrated by p53 small interfering RNA (siRNA) sensitive p21 upregulation. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | tumor protein p53 | Homo sapiens |
| 2 | Inhibition of E6-mediated p53 proteasomal degradation by MG132 resulted in elevated levels of active p53 as demonstrated by p53 small interfering RNA (siRNA) sensitive p21 upregulation. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | tumor protein p53 | Homo sapiens |
| 3 | Inhibition of E6-mediated p53 proteasomal degradation by MG132 resulted in elevated levels of active p53 as demonstrated by p53 small interfering RNA (siRNA) sensitive p21 upregulation. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | tumor protein p53 | Homo sapiens |
| 4 | Although p53 siRNA partially inhibited MG132-induced DR5 upregulation in HeLa and SiHa, no effect on rhTRAIL-induced apoptosis was observed. | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | tumor protein p53 | Homo sapiens |